arrow
H

Hilary Lewis

AstraZeneca
H指数:14
被引数:1,227

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolism-driven in vitro/in vivo disconnect of an oral ERα VHL-PROTAC
2024-05-135
OAAI
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance

下一代口服选择性雌激素受体降解剂Camizestrant (AZD9833) 抑制ER乳腺癌生长并克服内分泌和CDK4/6抑制剂抗性

2023-09-1916
OAAI
Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRASG12C with Demonstrable CNS Penetration

AZD4747的发现,这是一种有效且选择性的突变体GTPase KRASG12C抑制剂,具有明显的中枢神经系统穿透性

2023-07-0311
PRE
AZD4625 is a Potent and Selective Inhibitor of KRASG12C
2022-08-052
OAAI
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the MutantGTPase KRASG12C

突变gtpase KRASG12C的共价变构抑制剂AZD4625的发现

2022-04-2637
PRE
Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis

GLP-1R和GCGR双激动剂可通过调节线粒体功能和脂肪生成来解决NASH和肝纤维化

2020-05-21170
OAAI
Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors
2020-05-1552
OAAI
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C
2020-02-0560
PREAI
Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3
2015-04-1382
PREAI